Navigation Links
Genetic variant predicts antipsychotic response for schizophrenia patients by ethnicity
Date:1/8/2008

nd the response to antipsychotic treatment. Dr. Krystal adds, While this type of information is not yet ready to guide clinical practice, since the RGS4 variants explain only a small component of overall patterns of treatment response, these data provide an example of pharmacogenomics, the approach that will very likely ultimately guide treatment.


'/>"/>

Contact: Jayne Dawkins
ja.dawkins@elsevier.com
215-239-3674
Elsevier
Source:Eurekalert

0

GOOD

Page: 1 2

Related biology news :

1. Does the desire to consume alcohol and tobacco come from our genetic makeup?
2. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
3. Many parents at-risk for cancer disclose genetic test results to children
4. Genetics determine optimal drug dose of common anticoagulant
5. Claims of sex-related differences in genetic association studies often not properly validated
6. American College of Medical Genetics responds to new FDA labeling decision for warfarin
7. UNC study questions FDA genetic-screening guidelines for cancer drug
8. Genome study shines light on genetic link to height
9. Selexis Announces Advanced Approach to Maximize Power of Genetic Elements for Rapid Development of High Performance Cell Lines
10. Genes, Environment and Health Initiative invests in genetic studies, environmental monitoring
11. Rutgers Genetics receives $7.8 million for autism research

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...DGE, Mass. (November 26, 2009) Whitehead research...r human cells to pinpoint specific genes and prote... Science . , In most human cell cultures genes ...father and one from the mother. Gene inactivation ...one copy is inactivated, the second copy usually r...
(Date:11/26/2009)...methicillin-resistant Staphylococcus Aureus ) and...tion as low-temperature plasma prototype devices h...unfailing bactericidal cocktails. , Two prototyp...isinfection of healthy skin (e.g. hands and feet) ...pose a lethal threat; and another to shoot bacteri...
(Date:11/25/2009)...n, a hormone produced in the stomach, may be used ...f Parkinson,s disease, Yale School of Medicine res...ssue of the Journal of Neuroscience . , Parkins...ne neurons in an area of the midbrain known as the...ne production. Reduced production of dopamine in ...
Breaking Biology News(10 mins):Knockouts in human cells point to pathogenic targets 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Hormone ghrelin can boost resistance to Parkinson's disease 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 1Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 2Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 3Ovarian transplantation 3A New technique gives greatly improved results in this delicate operation 9049 4Working to conserve endangered Playboy bunnies 9046 1Working to conserve endangered Playboy bunnies 9046 2Kendle Names Jarrod Pontius Chief Legal Officer 12829 1Kendle Names Jarrod Pontius Chief Legal Officer 12829 2
...tiple strains of the flu virus, circulating in a p...nes and create a new virus, one capable of infecti...he open-access journal PLoS Biology. This finding ...which viral strains will attack during upcoming fl..., In the first large-scale effort to sequence the ...
...a clever bit of biology called site-specific recom...to another organism, and perform a sort of graftin...into a chromosome of the target cell. The process ...at cause drug resistance or transmit viruses that ...kemias or other cancers. , But what do the surgeon...
... research on a bacterium that can survive encounte...ned scientists, belief that these plentiful white ... our immune system will permit or prevent bacteria...released today online in The Journal of Immunology...ories (RML), part of the National Institute of All...
Other Biology News:Enlisting genomics to understand flu evolution 2Brown-Harvard team solves mobile DNA's surgical sleight-of-hand 2Scientists reveal how disease bacterium survives inside immune system cell 2Scientists reveal how disease bacterium survives inside immune system cell 3
(Date:11/24/2009)...ue Marble Energy Corp. announced today that the co...(OPDA) were recently awarded $2 million by Washing...d (CERB) in a private/public partnership to constr...inery in Lincoln County, WA. ,, "This investm...r biorefinery and bring over 70 green jobs to Linc...
(Date:11/24/2009)... been met for patients with advanced-stage, or ...Nov. 24 /PRNewswire-FirstCall/ - AEterna Zentaris ... global biopharmaceutical company focused on endoc...e efficacy data from a Phase 2 study with its targ...ly AN-152), in patients with advanced or recurrent...
(Date:11/24/2009)...e-FirstCall/ -- Shire plc (LSE: SHP,NASDAQ: SHPG...y, today,announced that it has submitted a MAA to ...fa, the company,s enzyme replacement therapy in de...ase. This is the third marketing,application for v...evious,submissions in the United States and Canada...
(Date:11/24/2009)...Newswire-FirstCall/ -- Genomic Health, Inc. (Nasda...ic Health,s Executive Chairman, will present at th... in New York City on Tuesday, December 1, 2009 at ...quently archived webcast of the presentation, visi...,s website at http://investor.genomichealth.com ....
Breaking Biology Technology:Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...orks Corp. has completed an SAS 70 Type II Audit ...d on Monday. , ,The SAS 70 Type IIauditand the Sys...ng benchmarks, formulated by the American Institut...ervice providers can report control activities and...SAS 70 Audit is the primary means by which a servi...
... joined the board of directors of Neurognostics, ...stics, which spun out of the Medical College of Wi...ng (fMRI) products and services , ,Silva-Craig is ...on Inc., which he joined in March, 2001. Emageon ...rvices. Prior to joining Emageon, Silva-Craig held...
...ications and other communications services will be... as representatives of nine western Wisconsin coun...art of the Synergy 2005 Conference , which will b...uncheon. , ,The counties engaged in the process ar..., Pierce, Polk and St. Croix. , ,Conference organi...
Other Biology Technology:Telecom issues are among focus of upcoming western Wisconsin conference 2Telecom issues are among focus of upcoming western Wisconsin conference 3
Fentanyl ELISA Kit, Single from Bio-Quant Inc.
Dengue Virus IgG ELISA Kit, Single from Bio-Quant Inc.
Human Laminin ELISA Kit, QuantiMatrix from Upstate
Rat Osteopontin EIA Kit from Assay Designs/Stressgen Bioreagents
Biology Products: